Page 36 - ITP_Guide-Final

15 แนวทางเวชปฏิิบััติิสำำาหรัับัการัวินิจฉัยและรัักษาโรัคเกล็ดเลอดติำ�าจากภููมิิค้มิกันในเด็ก
ื
ั
�
Childhood, 7th eds, orkin sH, nathan Dg, ginsburg D, look aT, Fisher
De, lux se, eds., Philadelphia: saunders; 2009. p. 1553-90.

11. Imbach P, wagner HP, Berchtold w, gaedicke g, Hirt a, Joller P, et al.
Intravenous immunoglobulin versus oral corticosteroids in acute immune
thrombocytopenic purpura in childhood. lancet 1985;2 (8453):464-8.
12. Cooper n, Bussel JB. The long-term impact of rituximab for childhood im-
mune thrombocytopenia. Curr Rheumatol Rep 2010;12:94-100.
13. george Jn, woolf sH, Raskob ge, wasser Js, aledort lM, Ballem PJ, et
al. Idiopathic thrombocytopenic purpura: a guideline Developed by explicit
Methods for The american society of Hematology. Blood 1996;1:3-40.
14. Provan D, newland a, Bolton-Maggs P, et al. guidelines for the investiga-
tion and children and in pregnancy. Br J Haematol 2003;120:574-96.
15. Carr JM, Kruskall Ms, Kaye Ja, Robinson sH. efficacy of platelet transfu-
sions in immune thrombocytopenia. am J Med 1986;80:1051-4.

16. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura.
Blood 2005;106:2224-51.
17. British Committee for standards in Haematology general Haematology
Task Force. guidelines for the investigation and management of idiopathic
thrombocytopenic purpura in adults, children and in pregnancy. Br J Hae-
matol 2003;120:574.
18. Rosthoj s, Hedlund-Treutiger I, Rajantie J, Zeller B, Jonsson og, elinder
g, et al. Duration and morbidity of newly diagnosed idiopathic thrombocy-

topenic purpura in children: a prospective nordic study of an unselected
cohort. J Pediatr 2003;143:302.
19. Medeiros D, Buchanan gR. Current controversies in the management of
idiopathic thrombocytopenic purpura during childhood. Pediatr Clin north
am 1996; 43:757.
20. lusher JM, lyer R. Idiopathic thrombocytopenic purpura in children. semin